Frank Torti Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Frank Torti.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Frank Torti. Frank Torti is Director in Arbutus Biopharma Corp ($TKMR) and Director in Axovant Sciences Ltd. ($AXON) and Director in Myovant Sciences Ltd. ($MYOV) and Director in Urovant Sciences Ltd. ($UROV) and Director in Health Sciences Acquisitions Corp ($HSAC).
Latest Insider Trading Transactions of Frank Torti
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TKMR, IMVT, MYOV, AXON, UROV
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 19 2021 | AXON | Sio Gene Therapies ... | Torti Frank | Director | Option Exercise | A | 2.47 | 42,000 | 103,740 | 42,000 | |
Mar 23 2021 | IMVT | Immunovant, Inc. | Torti Frank | Director | Option Exercise | A | 17.00 | 28,900 | 491,300 | 28,900 | |
Mar 23 2021 | IMVT | Immunovant, Inc. | Torti Frank | Director | Grant | A | 0.00 | 19,200 | 0 | 47,600 | 28.4 K to 47.6 K (+67.61 %) |
Jun 01 2020 | TKMR | Arbutus Biopharma ... | Torti Frank | Director | Option Exercise | A | 2.16 | 22,000 | 47,520 | 22,000 | |
May 18 2020 | HSAC | Immunovant, Inc. | Torti Frank | Director | Option Exercise | A | 19.01 | 42,600 | 809,826 | 42,600 | |
May 18 2020 | HSAC | Immunovant, Inc. | Torti Frank | Director | Grant | A | 0.00 | 28,400 | 0 | 28,400 | 0 to 28.4 K |
Apr 17 2020 | AXON | Axovant Gene Thera ... | Torti Frank | Director | Option Exercise | A | 3.45 | 17,500 | 60,375 | 17,500 | |
Dec 20 2019 | HSAC | Health Sciences Ac ... | Torti Frank | Director | Option Exercise | A | 8.43 | 3,765 | 31,739 | 3,765 | |
Dec 20 2019 | HSAC | Health Sciences Ac ... | Torti Frank | Director | Option Exercise | A | 8.43 | 11,488 | 96,844 | 11,488 | |
Dec 20 2019 | HSAC | Health Sciences Ac ... | Torti Frank | Director | Option Exercise | A | 7.86 | 893 | 7,019 | 893 | |
Dec 20 2019 | HSAC | Health Sciences Ac ... | Torti Frank | Director | Option Exercise | A | 7.86 | 137,617 | 1,081,670 | 137,617 | |
Aug 27 2019 | MYOV | Myovant Sciences L ... | Torti Frank | Director | Option Exercise | A | 7.65 | 58,608 | 448,351 | 58,608 | |
Aug 27 2019 | MYOV | Myovant Sciences L ... | Torti Frank | Director | Option Exercise | A | 7.65 | 58,608 | 448,351 | 58,608 | |
Aug 20 2019 | TKMR | Arbutus Biopharma ... | Torti Frank | Director | Option Exercise | A | 1.50 | 22,000 | 33,000 | 22,000 | |
Jul 11 2019 | UROV | Urovant Sciences L ... | Torti Frank | Director | Option Exercise | A | 8.78 | 25,000 | 219,500 | 25,000 | |
Apr 17 2019 | AXON | Axovant Sciences L ... | Torti Frank | Director | Option Exercise | A | 1.06 | 255,000 | 270,300 | 255,000 | |
Nov 27 2018 | TKMR | Arbutus Biopharma ... | Torti Frank | Director | Option Exercise | A | 4.72 | 44,000 | 207,680 | 44,000 | |
Nov 26 2018 | UROV | Urovant Sciences L ... | Torti Frank | Director | Option Exercise | A | 8.01 | 50,000 | 400,500 | 50,000 | |
Nov 26 2018 | UROV | Urovant Sciences L ... | Torti Frank | Director | Option Exercise | A | 8.01 | 50,000 | 400,500 | 50,000 | |
Nov 08 2018 | MYOV | Myovant Sciences L ... | Torti Frank | Director | Option Exercise | A | 22.83 | 45,000 | 1,027,350 | 45,000 | |
Oct 16 2018 | AXON | Axovant Sciences L ... | Torti Frank | Director | Option Exercise | A | 2.37 | 150,000 | 355,500 | 150,000 |
Page: 1